Global and United States Low Molecular Weight Heparin Market Research by Company, Type & Application 2013-2025
- HEY2618934
- 107 Pages
- May 2018
- Medical Devices
Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage. Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.
Market Segment as follows:
By Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
By Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
By Company
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
The main contents of the report including:
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Enoxaparin
1.1.2.2 Dalteparin
1.1.2.3 Tinzaparin
1.1.2.4 Fraxiparine
1.1.3 Market by Application
1.1.3.1 Treatment of Venous Thromboembolism
1.1.3.2 Complications of Pregnancy
1.1.3.3 Cardioversion of Atrial Fibrillation/Flutter
1.1.3.4 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 Global and Regional Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 Global and Regional Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 Global and Regional Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 Regional Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Aspen
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Sanofi-aventis
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Pfizer
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Opocrin
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 CSBIO
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Dongying Tiandong Pharmaceutical
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Changzhou Qianhong Bio-pharma
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Techdow
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Yantai Dongcheng Pharmaceutical Group
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
List Of Tables
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Aspen
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi-aventis
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Opocrin
Table Sales Revenue, Volume, Price, Cost and Margin of CSBIO
Table Sales Revenue, Volume, Price, Cost and Margin of Dongying Tiandong Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Changzhou Qianhong Bio-pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Techdow
Table Sales Revenue, Volume, Price, Cost and Margin of Yantai Dongcheng Pharmaceutical Group
List Of Figures
Figure Enoxaparin Market Size and CAGR 2013-2017 (Million USD)
Figure Enoxaparin Market Size and CAGR 2013-2017 (Volume)
Figure Enoxaparin Market Forecast and CAGR 2018-2025 (Million USD)
Figure Enoxaparin Market Forecast and CAGR 2018-2025 (Volume)
Figure Dalteparin Market Size and CAGR 2013-2017 (Million USD)
Figure Dalteparin Market Size and CAGR 2013-2017 (Volume)
Figure Dalteparin Market Forecast and CAGR 2018-2025 (Million USD)
Figure Dalteparin Market Forecast and CAGR 2018-2025 (Volume)
Figure Tinzaparin Market Size and CAGR 2013-2017 (Million USD)
Figure Tinzaparin Market Size and CAGR 2013-2017 (Volume)
Figure Tinzaparin Market Forecast and CAGR 2018-2025 (Million USD)
Figure Tinzaparin Market Forecast and CAGR 2018-2025 (Volume)
Figure Fraxiparine Market Size and CAGR 2013-2017 (Million USD)
Figure Fraxiparine Market Size and CAGR 2013-2017 (Volume)
Figure Fraxiparine Market Forecast and CAGR 2018-2025 (Million USD)
Figure Fraxiparine Market Forecast and CAGR 2018-2025 (Volume)
Figure Treatment of Venous Thromboembolism Market Size and CAGR 2013-2017 (Million USD)
Figure Treatment of Venous Thromboembolism Market Size and CAGR 2013-2017 (Volume)
Figure Treatment of Venous Thromboembolism Market Forecast and CAGR 2018-2025 (Million USD)
Figure Treatment of Venous Thromboembolism Market Forecast and CAGR 2018-2025 (Volume)
Figure Complications of Pregnancy Market Size and CAGR 2013-2017 (Million USD)
Figure Complications of Pregnancy Market Size and CAGR 2013-2017 (Volume)
Figure Complications of Pregnancy Market Forecast and CAGR 2018-2025 (Million USD)
Figure Complications of Pregnancy Market Forecast and CAGR 2018-2025 (Volume)
Figure Cardioversion of Atrial Fibrillation/Flutter Market Size and CAGR 2013-2017 (Million USD)
Figure Cardioversion of Atrial Fibrillation/Flutter Market Size and CAGR 2013-2017 (Volume)
Figure Cardioversion of Atrial Fibrillation/Flutter Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cardioversion of Atrial Fibrillation/Flutter Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Low Molecular Weight Heparin Market Size and CAGR 2013-2017 (Million USD)
Figure Global Low Molecular Weight Heparin Market Size and CAGR 2013-2017 (Volume)
Figure Global Low Molecular Weight Heparin Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Low Molecular Weight Heparin Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Low Molecular Weight Heparin Market Size and CAGR 2013-2017 (Million USD)
Figure United States Low Molecular Weight Heparin Market Size and CAGR 2013-2017 (Volume)
Figure United States Low Molecular Weight Heparin Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Low Molecular Weight Heparin Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Low Molecular Weight Heparin SWOT List
Figure Healthcare & Medical Porter's Five Forces
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
